Showing results (31-40 of 361) with videos related to
Sort By:
Pageof 37
Postgraduate Medical Journal|December 1, 1983
Acute polyarthritis following the use of Corynebacterium parvum vaccine (Coparvax) for malignant pleural effusionA M Lever, J Forsythe, P OxfordJournal of Medical Microbiology|August 1, 1985
Serum factors for opsonisation of non-typable Haemophilus influenzaeA M Lever, J Gross, A D WebsterJournal of Virology|April 1, 1995
Secondary structure model of the Mason-Pfizer monkey virus 5' leader sequence: identification of a structural motif common to a variety of retrovirusesG P Harrison, E Hunter, A M LeverThe Journal of General Virology|February 24, 1998
Development of cell lines stably expressing human immunodeficiency virus type 1 proteins for studies in encapsidation and gene transferD Haselhorst, J F Kaye, A M LeverThe Journal of Rheumatology|December 1, 1984
Persistent immunoglobulin deficiency after prednisolone and antiepileptic therapy in a C2 deficient patient with lupus-like syndromeP Woo, R S Pereira, A M LeverThorax|August 1, 1984
Nifedipine enhances the bronchodilator effect of salbutamolA M Lever, P A Corris, G J GibsonJournal of Virology|October 1, 1995
cis-acting sequences involved in human immunodeficiency virus type 1 RNA packagingJ F Kaye, J H Richardson, A M LeverJournal of Virology|November 17, 2001
The major human immunodeficiency virus type 2 (HIV-2) packaging signal is present on all HIV-2 RNA species: cotranslational RNA encapsidation and limitation of Gag protein confer specificityS D Griffin, J F Allen, A M LeverJournal of Virology|July 1, 1993
Packaging of human immunodeficiency virus type 1 RNA requires cis-acting sequences outside the 5' leader regionJ H Richardson, L A Child, A M LeverJournal of Virology|June 17, 1998
Functional analysis of the core human immunodeficiency virus type 1 packaging signal in a permissive cell lineG P Harrison, G Miele, E Hunter, et al.Pageof 37